148 related articles for article (PubMed ID: 11445843)
1. Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.
Seki N; Kodama J; Hashimoto I; Hongo A; Yoshinouchi M; Kudo T
Int J Oncol; 2001 Aug; 19(2):305-10. PubMed ID: 11445843
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis.
Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Clin Cancer Res; 2001 Sep; 7(9):2826-31. PubMed ID: 11555600
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798
[TBL] [Abstract][Full Text] [Related]
4. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Zhang J; Ito R; Oue N; Zhu X; Kitadai Y; Yoshida K; Nakayama H; Yasui W
Virchows Arch; 2003 Jun; 442(6):563-8. PubMed ID: 12719977
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer.
Tokunaga T; Nakamura M; Oshika Y; Abe Y; Ozeki Y; Fukushima Y; Hatanaka H; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Tamaoki N; Ueyama Y
Br J Cancer; 1999 Jan; 79(2):354-9. PubMed ID: 9888480
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
7. Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.
Cursiefen C; Masli S; Ng TF; Dana MR; Bornstein P; Lawler J; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1117-24. PubMed ID: 15037577
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.
Grossfeld GD; Ginsberg DA; Stein JP; Bochner BH; Esrig D; Groshen S; Dunn M; Nichols PW; Taylor CR; Skinner DG; Cote RJ
J Natl Cancer Inst; 1997 Feb; 89(3):219-27. PubMed ID: 9017002
[TBL] [Abstract][Full Text] [Related]
10. Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation.
Rae M; Mohamad A; Price D; Hadoke PW; Walker BR; Mason JI; Hillier SG; Critchley HO
J Clin Endocrinol Metab; 2009 Apr; 94(4):1443-50. PubMed ID: 19158196
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
[TBL] [Abstract][Full Text] [Related]
12. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
13. The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
Nakamura Y; Miyata Y; Takehara K; Asai A; Mitsunari K; Araki K; Matsuo T; Ohba K; Sakai H
Anticancer Res; 2019 May; 39(5):2317-2324. PubMed ID: 31092423
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Aghi M; Rabkin SD; Martuza RL
Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749
[TBL] [Abstract][Full Text] [Related]
15. [Expression of vascular endothelial growth factor and thrombospondin-1 in the ectopic and eutopic endometrium of women with endometriosis].
Tan X; Lang J; Liu D
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):727-30. PubMed ID: 16136892
[TBL] [Abstract][Full Text] [Related]
16. Expression of thrombospondin in non-small cell lung cancer.
Mascaux C; Martin B; Paesmans M; Verdebout JM; Verhest A; Vermylen P; Bosschaerts T; Ninane V; Sculier JP
Anticancer Res; 2002; 22(2B):1273-7. PubMed ID: 12168937
[TBL] [Abstract][Full Text] [Related]
17. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
18. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density.
Kasper HU; Ebert M; Malfertheiner P; Roessner A; Kirkpatrick CJ; Wolf HK
Virchows Arch; 2001 Feb; 438(2):116-20. PubMed ID: 11253112
[TBL] [Abstract][Full Text] [Related]
19. Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer.
Harada J; Miyata Y; Araki K; Matsuda T; Nagashima Y; Mukae Y; Mitsunari K; Matsuo T; Ohba K; Mochizuki Y; Sakai H
In Vivo; 2021; 35(3):1693-1701. PubMed ID: 33910854
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis.
Wu MP; Tzeng CC; Wu LW; Huang KF; Chou CY
Cancer J; 2004; 10(1):27-32. PubMed ID: 15000492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
